GENE ONLINE|News &
Opinion
Blog

Cardiovascular Disease
Potential Novel Anti-thrombotic Treatment by Ionis Pharmaceuticals
2022-07-28
Geneticists Find Loss of Y Chromosome in Aging Males Increases Risk of Heart Failure
2022-07-20
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
Verve Cleared to Test Gene Editing Drug for Heart Disease in Humans
2022-05-12
Merck Acquires Acceleron for $11.5 Billion, Gaining Access to a Phase 3 Cardiovascular Asset
2021-09-30
Verve Makes Successful Wall Street Debut on Back of its Promising Base Editor
2021-06-20
Encouraging Performance of Cardiovascular Drug Vindicates Novartis’ $9.7 Billion Buyout Deal
2020-09-06
Amgen to Serve Japanese Healthcare Market with Complete Ownership of 7 Year Joint Venture
2020-04-01
True to Analyst Predictions, Amarin’s Shares Crash Following Vascepa Patent Invalidation
2020-03-31
Peptide Therapeutics Market: Promise for a Painless Future
2020-03-18
Will Vascepa Receive a FDA Approval as a New Year Gift?
2019-12-02
2019 Asia-Pacific Extracellular Vesicles Conference Made the World-leading Experts Gathered in Taipei
2019-01-19
LATEST
BIODND – An AI-Powered Database That Breaks New Ground in Life Science Business Development
2023-11-29
GeneOnline’s Weekly News Highlights: Nov 20-Nov 24
2023-11-27
SK Bioscience and Hilleman Laboratories Join Forces for Ebola Vaccine Development
2023-11-23
BeiGene to Expand Oncology Pipeline Through ENSEM Therapeutics Partnership
2023-11-23
Advancing the Frontiers of Cell and Gene Therapy – An Interview with Dr. Shin Kawamata
2023-11-21
Astellas and Pfizer’s Drug Receives FDA Approval as Treatment for High-Risk Prostate Cancer Recurrence
2023-11-21
GeneOnline’s Weekly News Highlights: Nov 13-Nov 17
2023-11-20
EVENT
2023-11-30
2023 Healthcare+ EXPO・Taiwan
Taipei , Taiwan
Scroll to Top